ZNF198 protein, involved in rearrangement in myeloproliferative disease, forms complexes with the DNA repair-associated HHR6A/6B and RAD18 proteinsKUNAPULI, Padmaja; SOMERVILLE, Robert; STILL, Ivan H et al.Oncogene (Basingstoke). 2003, Vol 22, Num 22, pp 3417-3423, issn 0950-9232, 7 p.Article

Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disordersBIRGEGARD, Gunnar; BJÖRKHOLM, Magnus; SAMUELSSON, Jan et al.Haematologica (Roma). 2004, Vol 89, Num 5, pp 520-527, issn 0390-6078, 8 p.Article

Thrombopoietin from beginning to end : PLATELETSHITCHCOCK, Ian S; KAUSHANSKY, Kenneth.British journal of haematology. 2014, Vol 165, Num 2, pp 259-268, issn 0007-1048, 10 p.Article

Multiple oligomerization domains of KANK1-PDGFRβ are required for JAK2-independent hematopoietic cell proliferation and signaling via STAT5 and ERKMEDVES, Sandrine; NOËL, Laura A; MONTANO-ALMENDRAS, Carmen P et al.Haematologica (Roma). 2011, Vol 96, Num 10, pp 1406-1414, issn 0390-6078, 9 p.Article

Occurrence of the JAK2 V617F mutation in the Budd-Chiari syndromeCOLAIZZO, Donatella; AMITRANO, Lucio; TISCIA, Giovanni L et al.Blood coagulation & fibrinolysis. 2008, Vol 19, Num 5, pp 459-462, issn 0957-5235, 4 p.Article

Bone marrow fibrosis : pathophysiology and clinical significance of increased bone marrow stromal fibresKUTER, David J; BAIN, Barbara; MUFTI, Ghulam et al.British journal of haematology. 2007, Vol 139, Num 3, pp 351-362, issn 0007-1048, 12 p.Article

Phase II study of α2 interferon in the treatment of the chronic myeloproliferative disorders (E5487): A trial of the eastern cooperative oncology groupRADIN, Arthur I; KIM, Haesook T; GRANT, Barbara W et al.Cancer. 2003, Vol 98, Num 1, pp 100-109, issn 0008-543X, 10 p.Article

Splenectomy produces a rapid but transient decrease of the frequency of circulating CD34⁺ haematopoietic progenitor cells in primary myelofibrosisMASSA, Margherita; CAMPANELLI, Rita; LUPO, Letizia et al.British journal of haematology. 2011, Vol 152, Num 5, pp 665-667, issn 0007-1048, 3 p.Article

NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesisMICHAEL FORRESTER, A; GRABHER, Clemens; BERMAN, Jason N et al.British journal of haematology. 2011, Vol 155, Num 2, pp 167-181, issn 0007-1048, 15 p.Article

Genetic complementation of cytokine signaling identifies central role of kinases in hematopoietic cell proliferationKOH, Eugene Y; TONG CHEN; DALEY, George Q et al.Oncogene (Basingstoke). 2004, Vol 23, Num 6, pp 1214-1220, issn 0950-9232, 7 p.Article

A novel t(1;8)(q25;p11.2) translocation associated with 8p11 myeloproliferative syndromeYOSHIDA, Chikamasa; TAKEUCHI, Makoto; SADAHIRA, Yoshito et al.British journal of haematology. 2012, Vol 156, Num 2, pp 271-273, issn 0007-1048, 3 p.Article

Identification of JAK2^V617F in patients with polycythemia is highly correlated with conventional criteria for diagnosis of polycythemia veraGANLY, Peter; HANRAHAN, Vickie; BAKER, Bart et al.American journal of hematology. 2007, Vol 82, Num 1, pp 80-82, issn 0361-8609, 3 p.Article

Transgenic mice expressing Tel-FLT3, a constitutively activated form of FLT3, develop myeloproliferative diseaseBALDWIN, B. R; LI, L; TSE, K.-F et al.Leukemia. 2007, Vol 21, Num 4, pp 764-771, issn 0887-6924, 8 p.Article

Ringed sideroblasts with thrombocytosis : an uncommon mixed myelodysplastic/myeloproliferative disease of older adultsSHAW, Gene R.British journal of haematology. 2005, Vol 131, Num 2, pp 180-184, issn 0007-1048, 5 p.Article

Inferior vena cava thrombosis and its relationship with the JAK2V617F mutation and chronic myeloproliferative diseaseLINNEMANN, Birgit; KRAFT, Christiane; ROSKOS, Martin et al.Thrombosis research. 2012, Vol 129, Num 6, pp 720-724, issn 0049-3848, 5 p.Article

Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disordersTSIMBERIDOU, Apostolia M; COLBURN, Dawn E; WELCH, Mary Alma et al.Cancer chemotherapy and pharmacology. 2003, Vol 52, Num 3, pp 229-234, issn 0344-5704, 6 p.Article

Phosphorylation of the SSBP2 and ABL proteins by the ZNF198-FGFR1 fusion kinase seen in atypical myeloproliferative disorders as revealed by phosphopeptide-specific MSKASYAPA, Chitta; GU, Ting-Lei; NATARAJAN, Lalitha et al.Proteomics (Weinheim. Print). 2009, Vol 9, Num 16, pp 3979-3988, issn 1615-9853, 10 p.Article

Clinical features of hypereosinophilic syndrome : FIP1L1-PDGFRA fusion gene-positive disease is a distinct clinical entity with myeloproliferative features and a poor response to corticosteroidMIYAZAWA, Keisuke; KAKAZU, Naoki; OHYASHIKI, Kazuma et al.International journal of hematology. 2007, Vol 85, Num 1, pp 5-10, issn 0925-5710, 6 p.Article

Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia : molecular classification and treatment optionsNIEMEYER, Charlotte Marie; KRATZ, Christian Peter.British journal of haematology. 2008, Vol 140, Num 6, pp 610-624, issn 0007-1048, 15 p.Article

JAK2V617F Mutation in Patients with Portal Vein ThrombosisBAYRAKTAR, Yusuf; HARMANCI, Ozgur; BÜYÜKASIK, Yahya et al.Digestive diseases and sciences. 2008, Vol 53, Num 10, pp 2778-2783, issn 0163-2116, 6 p.Article

Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseasesOPPLIGER LEIBUNDGUT, Elisabeth; HORN, Michael Peter; BRUNOLD, Claudio et al.Haematologica (Roma). 2006, Vol 91, Num 11, pp 1465-1472, issn 0390-6078, 8 p.Article

Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseasesPANTELI, Katerina E; HATZIMICHAEL, Eleftheria C; BOURANTA, Paraskevi K et al.British journal of haematology. 2005, Vol 130, Num 5, pp 709-715, issn 0007-1048, 7 p.Article

Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemiaMARTA, Rosana; GOETTE, Nora; LEV, Paola et al.Haematologica (Roma). 2004, Vol 89, Num 6, pp 657-663, issn 0390-6078, 7 p.Article

Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasmBARRIO, Santiago; GALLARDO, Miguel; MARTINEZ-LOPEZ, Joaquin et al.British journal of haematology. 2013, Vol 161, Num 5, pp 667-676, issn 0007-1048, 10 p.Article

Risks of myeloid malignancies in patients with autoimmune conditionsANDERSON, L. A; PFEIFFER, R. M; LANDGREN, O et al.British journal of cancer. 2009, Vol 100, Num 5, pp 822-828, issn 0007-0920, 7 p.Article